IP Library Granted Patent US 8,498,882
Granted Patent B2
US 8,498,882 · App. 13/147,835 · Granted Jul 30, 2013

System for making available individual or pooled, also anonymous patient data on the basis of molecular genome, transcriptome, proteome, epigenome, or metabolome data

Inventor: Thomas Klein (Potsdam, DE)
Assignee: Cytolon AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,498,882
App. No.
13/147,835
Granted
Jul 30, 2013
Kind
B2
Abstract

The invention relates to a system for automatically, rapidly, and dynamically funding biological cells for transplantion, treatment, or research purposes between collection centers or banks (storage places) and hospitals, transplant centers, or research facilities, monitoring and assisting with processes from the transmission of requests, the delivery of cell preparation suitable for allogeneic transplantation, and the use of the found preparations to the monitoring of the result in the patient, and making said data available for statistical and other purposes, wherein samples are taken before and after the transplantation to analyze genomes, proteomes, transcriptomes, epigenomes, and/or metbolomes.

Claims (1805)

1. A system for allocating and selecting umbilical cord blood preparations, for transplantations, therapies and/or research purposes, wherein the system comprises data processing equipment including multiple processing units connected via a network of said multiple processing units via which data is exchanged,

wherein

said one or more processing units are configured to:

store experience data of umbilical cord blood preparations imputed into a computer via one or more input devices and storing on a storage medium,

store inquiry data of a potential recipient or patient on a storage medium,

store preset search criteria,

compare the experience data with the inquiry data, and automatically evaluate the search being effected, and/or

effect order processing and tracking on the basis of this evaluation, wherein the umbilical cord blood preparation being ordered via the network, and wherein

the multiple processing units are configured to arrange and select potential umbilical cord blood preparations according to HLA match, patient weight, number of nucleated cells (TNC) and number of hematopoietic cells (CD34+),

metabolites of the umbilical cord blood preparations, of the recipient and/or donor are determined prior to and after said transplantation and/or therapy and are stored by one or more of said processing units, and

genome, proteome, transcriptome and/or epigenome analyses are carried out and are stored by one or more of said processing units, wherein in said allocation and selecting (a) at least one collection center and/or storage site and (b) at least one clinic, transplant center and/or research facility, communicate with each other via wired and/or wireless connections

wherein the one or more processing units are configured to execute

a patient search that comprises determining patient-compatible preparations in accordance with one or more of the following:

name and identification of clinic or transplantation center,

names of coordinator and attending physician, including contact data,

status of clinic with regard to international certifications (e.g. FACT),

average number of UCB transplantations in the inquiring clinic during the last three years,

name of patient, insurance number and other accounting information,

patient's medical history,

indication and therapy proposal of attending physician,

urgency according to defined classification,

HLA type of patient,

blood group of patient,

weight of patient,

ethnic group of patient,

sex of patient,

age of patient,

known allelic characteristics of patient and/or data of DNA typing,

first treatment or re-treatment,

wherein the one or more of said processing units are configured to produce short list(s) of potential umbilical cord preparations using the following settings:

ML

Prep

:

_

=

{

6

:

HLA

Prep

and

HLA

Pat

match

in

6

out

of

6

values

and

blood

group

compatibility

5

:

HLA

Prep

and

HLA

Pat

match

in

5

out

of

6

values

and

blood

group

compatibility

4

:

HLA

Prep

and

HLA

Pat

match

in

5

out

of

6

values

and

blood

group

compatibility

Preparation

not

included

:

other

wherein ML Prep =match level in accordance with HLA compatibility between preparation and patient,

CF

Prep

:=

{

3

×

10

7

:

ML

Prep

=

6

4

×

10

7

:

ML

Prep

=

5

5

×

10

7

:

ML

Prep

=

4

wherein CF Prep =cell factor defining required number of cells per kg of patient weight at corresponding match level,

CN

Prep

:=

TNC

Prep

CF

Prep

wherein CN Prep =classification number of a preparation allowing arrangement of preparations in accordance with TNC and match level, and wherein

the short list(s) of preparations to be considered for single transplants are produced using the following setting:

SL

Single

:=

{

p

Prep

CN

p

BW

Pat

1

/

kg

ML

Prep

4

}

wherein SL Single =short list of preparations to be considered for single transplants,

and wherein the classifications of preparations in the short list are made according to the following criteria:

Classification

1

=

initial

ranking

according

to

match

level

,

followed

by

classification

number

,

followed

by

CD

34

+

Classification

1

(

SL

)

:=

{

p

1

SL

,

p

2

SL

either

ML

p

1

>

ML

p

2

or

ML

p

1

=

ML

p

2

CN

p

1

>

CN

p

2

or

ML

p

1

=

ML

p

2

CN

p

1

=

CN

p

2

CD

34

p

1

CD

34

p

2

and

Classification

2

=

initial

ranking

according

to

classification

number

,

followed

by

match

level

,

followed

by

CD

34

+

Classification

2

(

SL

)

:=

{

p

1

SL

,

p

2

SL

either

CN

p

1

>

CN

p

2

or

CN

p

1

=

CN

p

2

ML

p

1

>

ML

p

2

or

CN

p

1

=

CN

p

2

ML

p

1

=

ML

p

2

CD

34

p

1

+

CD

34

p

2

+

wherein

Prep=umbilical cord blood preparation

Pat=patient

HLA Pat =HLA values of patient

HLA Prep =HLA values of preparation

TNC Prep =number of nucleated cells of preparation

BW Pat =body weight of patient in kg

CD34+ Prep =number of CD34+ cells of a preparation

P1, P2=preparation 1 selected, preparation 2 selected.

2. The system according to claim 1 ,

wherein the one or more of said processing units are configured to acquire data regarding

umbilical cord blood preparations with a data set during data processing, which data set comprises the following parameters:

name and identification of the UCB storage bank (UCB bank),

status of the UCB storage bank with regard to international certifications, preferably FACT,

process reliability of the UCB bank according to classification,

contact in the respective bank, including contact data,

identification number of preparation,

medical history of mother, child and family according to anamnesis form of the maternity clinic,

ethnic group of mother, father and/or child,

sex of child,

date of initial storage of preparation,

details of preparation processing,

blood group of preparation,

HLA type of preparation,

cell count (TNC) of preparation,

cell count (CD34+) of preparation,

viral status of preparation,

allelic characteristics of preparation, and/or

parameters of molecular diagnoses and analyses of genome, transcriptome, proteome, epigenome and/or metabolome,

said data set being stored on a storage medium and/or processing unit.

3. The system according to claim 1 , wherein metabolites from tissues, mucous membranes, lungs, liver, blood, intestines, faeces, kidneys and/or urine are determined.

4. The system according to claim 1 ,

Wherein the one or more processing units are configured to execute a patient search that determines patient-compatible preparations in accordance with the following classification and/or exclusion criteria:

HLA type of patient, and

weight of patient.

5. The system according to claim 1 ,

wherein

the following further classification and/or exclusion criteria are implemented:

preparations having a CD34+ cell count above 10% of the TNC count,

exclusion of preparations wherein less than 75% of the CD34+ cells survived and/or were activated in a CA (colony assay),

blood group identity,

ethnic identity,

gender,

age of preparation,

accreditation standard and/or

ranking of the UCB bank.

6. The system according to claim 1 ,

wherein one or more of said processing units are configured to allocate double or multiple transplantations.

7. The system according to claim 6 ,

wherein one or more of said processing units are configured to perform the selection of multi-cord preparations according to the following classification criteria:

ML

P

1

P

2

:=

{

6

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

6

out

of

6

values

and

blood

group

compatibility

5

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

5

out

of

6

values

and

blood

group

compatibility

4

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

4

out

of

6

values

and

blood

group

compatibility

Preparation

not

included

:

other

wherein ML P1P2 =mutual compatibility of 2 preparations, and

BL

Multi

:=

{

p

Prep

CN

p

BW

Pat

<

1

/

kg

ML

Prep

4

}

wherein BL Multi =basic list to determine the selection list for multiple preparations, and wherein said one or more processing units are configured to prepare a short list of preparations to be included in multiple transplants according to the following formula:

SL

Multi

:=

{

p

1

BL

Multi

,

p

2

BL

Multi

ML

p

1

p

2

4

CN

p

1

+

CN

p

2

BW

Pat

1

}

.

SL Muiti =short list of preparations to be included in multiple transplants,

wherein

P1=preparation 1 selected,

P2=preparation 2 selected, and

Multi=multiple transplants.

8. A method for selecting a cell preparation suitable for allogenic transplantation comprising

providing a system wherein said system allocates and selects umbilical cord blood preparations, for transplantations, therapies and/or research purposes between (a) at least one collection center and/or storage site and (b) at least one clinic, transplant center and/or research facility, (a) and (b) communicating with each other via wired and/or wireless connections on multiple processing units and being connected via a network of said multiple processing units via which data are exchanged,

and wherein the method further comprises

inputting experience data of umbilical cord blood preparations in a computer and storing said data on a first storage medium,

inputting inquiry data of a potential recipient or patient and storing the data on said first or a second storage medium,

presetting search criteria on said first, second or a further storage medium and/or one of said processing units,

conducting a search, said search comprising comparing the experience data with the inquiry data, and an automatic evaluation of the search being effected, and/or

effecting order processing and tracking on the basis of this evaluation, and the umbilical cord blood preparation being ordered via the network,

wherein

potential umbilical cord blood preparations are arranged and selected according to HLA match, patient weight, number of nucleated cells (TNC) and number of hematopoietic cells (CD34+) and, in addition,

metabolites of the umbilical cord blood preparations, of the recipient and/or donor are determined prior to and after transplantation and/or therapy of biological cells and/or tissues, and genome, proteome, transcriptome and/or epigenome analyses are carried out and executing

a patient search comprising:

determining patient-compatible preparations in accordance with one or more of the following:

name and identification of clinic or transplantation center,

names of coordinator and attending physician, including contact data,

status of clinic with regard to international certifications (e.g. FACT),

average number of UCB transplantations in the inquiring clinic during the last three years,

name of patient, insurance number and other accounting information,

patient's medical history,

indication and therapy proposal of attending physician,

urgency according to defined classification,

HLA type of patient,

blood group of patient,

weight of patient,

ethnic group of patient,

sex of patient,

age of patient,

known allelic characteristics of patient and/or data of DNA typing,

first treatment or re-treatment,

wherein the one or more processing units are configured to produce short list(s) of potential umbilical cord preparations using the following settings:

ML

Prep

:=

{

6

:

H

L

A

Prep

and

H

L

A

Pat

match

in

6

out

of

6

values

and

blood

group

compatibility

5

:

H

L

A

Prep

and

H

L

A

Pat

match

in

5

out

of

6

values

and

blood

group

compatibility

4

:

H

L

A

Prep

and

H

L

A

Pat

match

in

4

out

of

6

values

and

blood

group

compatibility

Preparation

not

included

:

other

wherein ML Prep =match level in accordance with HLA compatibility between preparation and patient,

CF

Prep

:=

{

3

×

10

7

:

ML

Prep

=

6

4

×

10

7

:

ML

Prep

=

5

5

×

10

7

:

ML

Prep

=

4

wherein CF Prep =cell factor defining required number of cells per kg of patient weight at corresponding match level,

CN

Prep

:=

T

N

C

Prep

CF

Prep

wherein CN Prep =classification number of a preparation allowing arrangement of preparations in accordance with TNC and match level, and wherein

the short list(s) of preparations to be considered for single transplants are produced using the following setting:

SL

Single

:=

{

p

Prep

CN

p

BW

Pat

1

/

kg

ML

Prep

4

}

wherein SL Single =short list of preparations to be considered for single transplants,

and wherein the classifications of preparations in the short list are made according to the following criteria:

Classification

1

=

initial

ranking

according

to

match

level

,

followed

by

classification

number

,

followed

by

CD

34

+

Classification

1

(

SL

)

:=

{

p

1

SL

,

p

2

SL

either

ML

p

1

>

ML

p

2

or

ML

p

1

=

ML

p

2

CN

p

1

>

CN

p

2

or

ML

p

1

=

ML

p

2

CN

p

1

=

CN

p

2

CD

34

p

1

CD

34

p

2

Classification

2

=

initial

ranking

according

to

classification

number

,

followed

by

match

level

,

followed

by

CD

34

+

Classification

2

(

SL

)

:=

{

p

1

SL

,

p

2

SL

either

CN

p

1

>

CN

p

2

or

CN

p

1

=

CN

p

2

ML

p

1

>

ML

p

2

or

CN

p

1

=

CN

p

2

ML

p

1

=

ML

p

2

CD

34

p

1

+

CD

34

p

2

+

wherein

Prep=umbilical cord blood preparation

Pat=patient

HLA Pat =HLA values of patient

HLA Prep =HLA values of preparation

TNC Prep =number of nucleated cells of preparation

BW Pat =body weight of patient in kg

CD34+ Prep =number of CD34+ cells of a preparation

P1, P2=preparation 1 selected, preparation 2 selected.

9. The method according to claim 8 ,

further comprising coordinating between hospital, transplant center and attending physician.

10. The method according to claim 8 ,

wherein the system is used in automatic and full-range selection of single-cord or multi-cord transplants.

11. The method according to claim 8 ,

wherein

the search criteria of the system are adapted to the registered criteria and/or parameters.

12. The method according to claim 8 ,

wherein

the system uses a matrix to display the results obtained using the search criteria and visually displays the results.

13. The method according to claim 8 ,

wherein

the system uses statistics relating to the expected cost and required time to assess the status of the determination of classification criteria.

14. The method according to claim 8 ,

further comprising a patient search comprising:

determining patient-compatible preparations in accordance with the following classification and/or exclusion criteria:

HLA type of patient, and

weight of patient.

15. The method of claim 8 ,

wherein the system is used in the allocation of double or multiple transplantations.

16. The method of claim 15 ,

wherein the selection of multi-cord preparations is performed according to the following classification criteria:

ML

P

1

P

2

:=

{

6

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

6

out

of

6

values

and

blood

group

compatibility

5

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

5

out

of

6

values

and

blood

group

compatibility

4

:

H

L

A

Prep

1

and

H

L

A

Prep

2

match

in

4

out

of

6

values

and

blood

group

compatibility

Preparation

not

included

:

other

ML P1P2 =mutual compatibility of 2 preparations, and

BL

Multi

:=

{

p

Prep

CN

p

BW

Pat

<

1

/

kg

ML

Prep

4

}

wherein BL Multi =basic list to determine the selection list for multiple preparations, and wherein said one or more processing units are configured to prepare a short list of preparations to be included in multiple transplants according to the following formula:

SL

Multi

:=

{

p

1

BL

Multi

,

p

2

BL

Multi

ML

p

1

p

2

4

CN

p

1

+

CN

p

2

BW

Pat

1

}

.

SL Multi =short list of preparations to be included in multiple transplants,

wherein

P1=preparation 1 selected,

P2=preparation 2 selected, and

Multi=multiple transplants.

Assignments (2)
CHANGE OF NAME Recorded Feb 23, 2017
From: CYTOLON AG
To: PIRCHE AG
Reel/Frame 041797/0941 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2011
From: KLEIN, THOMAS
To: CYTOLON AG
Reel/Frame 027257/0929 →
Priority Claims (1)
EP 09075057 · Feb 6, 2009 · regional
Continuity (2)
Provisional Application 61150383 · Feb 6, 2009
Related Publication 20120123792A1 · May 17, 2012